HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of ultrafiltration, nesiritide, and usual care in acute decompensated heart failure.

Abstract
To study the short-term effects of initial treatment strategies for acute decompensated heart failure, 25 patients treated with ultrafiltration (UF) were retrospectively compared with 25 patients treated with usual care (UC) and 25 patients treated with UC plus adjunctive nesiritide infusion (UN), matched for age, sex, ejection fraction, etiology, and serum creatinine. The median length of hospitalization was 6 days for UF, 4 days for UC, and 6 days for UN. All-cause 30-day readmissions tended to be fewer in the UF (16%) compared with the UN (24%) or UC (24%) groups. All groups lost weight, although to a greater extent in the UF group (15.8 lb vs 6.3 lb in UC and 4.7 lb in UN). Concomitantly, UF manifested the greatest increase in serum urea nitrogen, creatinine, and the number of patients with creatinine increases of >0.5 mg/dL (44% vs 24% in UC and 20% in UN). In acute decompensated heart failure, UF appears to be more effective for volume removal and possibly prevention of all-cause hospital readmission to 30 days than UC or UN. These findings, as well as the effects on renal function and length of stay, need to be further evaluated in a prospective randomized study.
AuthorsCheryl Bartone, Syed Saghir, Santosh G Menon, Jayna Brosmer, Dean J Kereiakes, Wojciech Mazur, Eugene S Chung
JournalCongestive heart failure (Greenwich, Conn.) (Congest Heart Fail) 2008 Nov-Dec Vol. 14 Issue 6 Pg. 298-301 ISSN: 1751-7133 [Electronic] United States
PMID19076851 (Publication Type: Comparative Study, Journal Article)
Copyright(c) 2008 Le Jacq
Chemical References
  • Natriuretic Agents
  • Natriuretic Peptide, Brain
  • Creatinine
Topics
  • Aged
  • Blood Urea Nitrogen
  • Creatinine (blood)
  • Female
  • Heart Failure (blood, drug therapy, physiopathology, therapy)
  • Humans
  • Length of Stay
  • Male
  • Natriuretic Agents (therapeutic use)
  • Natriuretic Peptide, Brain (therapeutic use)
  • Retrospective Studies
  • Stroke Volume
  • Ultrafiltration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: